A paradigm for restenosis based on cell biology: Clues for the development of new preventive therapies

Journal of the American College of Cardiology

Volumn 17, Issue 3, 1991, Pages 758-769

  Forrester, James S ^a   Fishbein, Michael ^a   Helfant, Richard ^a   Fagin, James ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; CYCLOSPORIN; DACTINOMYCIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; GROWTH FACTOR; HEPARIN; RETINOID; VINCRISTINE;

CORONARY ARTERY DILATATION; HEART INFARCTION; HISTOLOGY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; WOUND HEALING;

EID: 0025756615     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(10)80196-2     Document Type: Review

References (109)

1. Relation to restenosis after coronary angioplasty to vasomotion of the dilated coronary arterial segment
2. Restenosis after coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute
3. Restenosis after successful coronary angioplasty: serial angiographic follow-up of 229 patients
4. Incidence of restenosis after successful coronary angioplasty: a time related phenomenon. A quanti- tative angiographic study in 342 consecutive patients at I, 2, and 3 months
5. Restenosis after successful coronary angioplasty: the Montreal Heart Institute experience
6. Importance of stenosis morphology in the estimation of restenosis risk after elective coronary angioplasty
7. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation
8. Accelerated coronary arteriosclerosis in cardiac transplant recipients
9. A perspective of coronary disease seen through the arteries of living man
10. Angioscopic observation of the coronary luminal changes induced by coronary angioplasty
11. Changes of angioscopic macromorphology following coronary angioplasty (abstr)
12. Intimai proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after coronary angioplasty
13. Morphology after transluminal angioplasty in human beings
14. Intimai hyperplasia as a cause of restenosis after coronary angioplasty
15. Pathologic changes induced by repeated coronary angioplasty
16. Histopathologic phenomena at the site of coronary angioplasty
17. The disease-free wall in coronary atherosclerosis: its relation to degree of obstruction
18. Morphologic correlates of coronary angiographic patterns at the site of coronary angioplasty
19. Effects of coronary angioplasty on atherosclerotic plaques and relation of plaque composition and arterial size to outcome
20. Arterial changes after coronary angioplasty: results at autopsy
21. Coronary angioplasty: histopathological analysis of nine necropsy cases
22. Coronary arterial findings after accidental death immediately after successful coronary angioplasty
23. Coronary angioplasty: morphological findings in 3 patients
24. Pathological findings after coronary angioplasty
25. Coronary artery restenosis following transluminal coronary angioplasty
26. “Crackers, breakers, stretchers, drillers, scrapers, shavers, burners, welders, and melters”: the future treatment of atherosclerotic coronary artery disease?: a clinical-morphologic assessment
27. The mechanism of transluminal angioplasty: evidence for formation of aneurysms in experimental atherosclerosis
28. Balloon angioplasty: natural history of the pathophysiologic response to injury in a pig model
29. Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro
30. Kinetics of cellular proliferation after arterial injury. V. Role of acute distension in the induction of smooth muscle proliferation
31. Transluminal atherectomy for occlusive peripheral vascular disease
32. Arterial regeneration over polydioxanone prostheses in the rabbit
33. Overview and general considerations of wound repair
34. Enhancement of wound healing by topical treatment with epidermal growth factor
35. Growth factors: soluble mediators of wound repair and ocular fibrosis
36. Classification and treatment of chronic nonhealing wounds
37. The biology of platelet-derived growth factor
38. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury
39. Angiogenic factors
40. Dual control of cell growth by somatomedins and platelet-derived growth factor
41. Epidermal growth factor and related molecules
42. Somatomedins: do they play a pivotal role in wound healing? Growth factors and other aspects of wound healing
43. Transforming growth factor beta: biochemistry and roles in embryogenesis, tissue repair and remodeling and carcinogenesis
44. Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells
45. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix
46. Induction of insulin-like growth factor-1 m-RNA in rat aorta after balloon denudation
47. Transforming growth factor beta levels in rat wound chambers
48. Arterial smooth muscle: a multifunctional mesenchymal cell
49. Regulation of vascular smooth muscle cell growth by heparin and heparin sulfates
50. Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth
51. Endothelial cell influences on vascular smooth muscle phenotype
52. Cell biology of arterial proteoglycans
53. Transforming growth factor beta regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans
54. Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration
55. Brayton CF, Agarwal LA, Welt FGP, Weksler BB: Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor beta/alpha,-macroglobulin inactive complex
56. Clinical applications of heparin-binding growth factors
57. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium
58. Fibronectin in experimental granulation tissue
59. Glycosaminoglycans in corneal regeneration
60. Rate of chondroitin sulfate formation in wound healing
61. Significance of quiescent smooth muscle migration in the injured rat carotid artery
62. Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening
63. Endothelial regeneration. III. Time course of intimai change after small defined injury to rat endothelium
64. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels
65. Glycosaminoglycan composition and biosynthesis in the endothelium-covered neointima and de-endothelialized rabbit aorta
66. Intimai healing: the pattern of reendothelialization and intimai thickening
67. Mechanisms of stenosis after arterial injury
68. Replication of smooth muscle cells in vascular disease
69. Mechanisms of arterial graft healing: rapid transmural capillary ingrowth provides a source of intimai endothelium and smooth muscle in porous PTFE prostheses
70. Measurement of collagen biosynthesis during wound healing
71. Immediate and long term effects of angioplasty-balloon dilation on normal rabbit iliac artery
72. Paralysis of arteries by intraluminal balloon dilation
73. Balloon catheter injury to rabbit carotid artery. I. Changes in smooth muscle phenotype
74. Platelet deposition at angioplasty sites and its relation to restenosis in human iliac and femoropopliteal arteries
75. Platelet accumulation in experimental angioplasty: time course and relation to vascular injury
76. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty
77. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery
78. Aspirin and dipyridamole in the prevention of restenosis after coronary angioplasty
79. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study
80. Effect of Cortisol on the proliferation and protein synthesis of human aortic smooth muscle cells in culture
81. Research on coronary artery stenosis: restenosis after coronary angioplasty: potential biological determinants and role of intimai hyperplasia
82. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty
83. Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury
84. Does Max-EPA lower the risk of restenosis after PTCA: a prospective randomized trial (abstr)
85. Randomised trial of fish oil for prevention of restenosis after coronary angioplasty
86. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids
87. Can oral fish oil supplement minimize restenosis after coronary angioplasty? (abstr)
88. High dose omega-3 fatty acid supplmentation reduces clinical restenosis after coronary angioplasty (abstr)
89. Low dose of antitumor agents prevents smooth muscle cell proliferation after endothelial injury (abstr)
90. Immunodetection and quantitation of the two forms of transforming growth factor-beta (transforming growth factor-beta, and transforming growth factor-beta2) secreted by cells in culture
91. Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin
92. Biology of disease: a reassessment of endothelial injury and arterial lesion formation
93. Inhibition of vascular smooth muscle cell proliferation in culture by pentosan polysulphate and related compounds
94. Results of a randomized trial of heparin and aspirin vs aspirin alone for prevention of acute closure and restenosis after angioplasty (PTCA) (abstr)
95. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury
96. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells
97. Morphological aspects of secretion in the arterial smooth muscle cell, with special reference to the Golgi complex and microtubular cytoskeleton
98. Inhibitory effect of dimethyl sulfoxide on the proliferation of cultured arterial smooth muscle cells', relationship to the cytoplasmic microtubules
99. Retinoid effects on fibroblast proliferation and collagen synthesis in vitro and on fibrotic disease in vivo
100. Retinole acid in the treatment of keloids
101. Prevention of restenosis by lovastatin (abstr)
102. 2 in cultured rabbit aortic smooth muscle cells
103. Prostaglandin E, inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor
104. Antiatherogenic activity of FR 34235 (nilvadipine), a new potent calcium antagonist: effect on cuff induced intimai thickening of rabbit carotid artery
105. The calcium antagonist nifedipine inhibits arterial smooth muscle proliferation
106. Inhibitory effects of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size
107. Turbulent fluid shear stress induces vascular endothelial cell turnover in vitro